Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...
Alloy Therapeutics Inc., a biotechnology ecosystem company, has joined forces with Pfizer Inc., to develop a new platform ...
Healthshots on MSN8d
Future Perspectives and Challenges in Recombinant Antibody DevelopmentRecombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), announced ...
More information: Bo Shi et al, Heavy-chain antibody targeting of CD38 NAD+ hydrolase ectoenzyme to prevent fibrosis in ...
To do this, scientists typically integrate the genes encoding the relevant antibody’s subunits, called the heavy and light chain, into a host cell line. Those with the best yields are grown ...
Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology ...
The HCAb Harbour Mice® platform is revolutionizing antibody development by producing unique heavy chain-only antibodies that are approximately half the size of conventional IgGs, offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback